Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 53, 2023 - Issue 8-9
76
Views
0
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

The metabolite profiling of YR-1702 injection in human plasma, urine and feces by HPLC-Q-TOF-MS/MS

, , , , , , & show all
Pages 536-546 | Received 29 Aug 2023, Accepted 14 Oct 2023, Published online: 23 Oct 2023

References

  • Bian Y, Sun M, Chen H, Ren G, Fu K, Yang N, Zhang M, Zhou N, Lu Y, Li N, et al. 2022. Metabolites identification and species comparison of Oroxylin A, an anti-cancer flavonoid, in vitro and in vivo by HPLC-Q-TOF-MS/MS. Xenobiotica. 52(2):165–176. doi: 10.1080/00498254.2021.2014080.
  • Childers WE, Abou-Gharbia MA. 2021. I’ll Be Back”: the Resurrection of Dezocine. ACS Med Chem Lett. 12(6):961–968. doi: 10.1021/acsmedchemlett.1c00233.
  • Choi SM, Kim Y, Lee J, Kim J-H, Lee T, Min BS, Kim JA, Lee S. 2020. Characterization of hydrocoptisonine metabolites in human liver microsomes using a high-resolution quadrupole-orbitrap mass spectrometer. Xenobiotica. 50(12):1423–1433. doi: 10.1080/00498254.2020.1795304.
  • Crabtree D, Ganty P. 2016. Common functional pain syndromes. BJA Education. 16(10):334–340. doi: 10.1093/bjaed/mkw010.
  • Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. 2022. CDC clinical practice guideline for prescribing opioids for pain — United States, 2022. MMWR Recomm Rep. 71(3):1–95. doi: 10.15585/mmwr.rr7103a1.
  • Dubin AE, Patapoutian A. 2010. Nociceptors: the sensors of the pain pathway. J Clin Invest. 120(11):3760–3772. doi: 10.1172/JCI42843.
  • Feng R, Zhang X, Yin J, Zhang Y, Ma Y, Zhang X, Zhang L, Li D. 2021. A comprehensive study of the metabolism of flavonoid oroxin B in vivo and in vitro by UHPLC-Q-TOF-MS/MS. J Pharm Biomed Anal. 197:113905. doi: 10.1016/j.jpba.2021.113905.
  • Gao H, Li J, Chen X, Sun Z, Cui G, Cheng M, Ding L. 2022. Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects. Front Pharmacol. 13:1064364. doi: 10.3389/fphar.2022.1064364.
  • Gharagozlou P, Hashemi E, DeLorey TM, Clark JD, Lameh J. 2006. Pharmacological profiles of opioid ligands at Kappa opioid receptors. BMC Pharmacol. 6(1):3. doi: 10.1186/1471-2210-6-3.
  • Hamilton RA, Garnett WR, Kline BJ. 1981. Determination of mean valproic acid serum level by assay of a single pooled sample. Clin Pharmacol Ther. 29(3):408–413. doi: 10.1038/clpt.1981.56.
  • Jasinski DR, Preston KL. 1985. Assessment of dezocine for morphine-like subjective effects and miosis. Clin Pharmacol Ther. 38(5):544–548. doi: 10.1038/clpt.1985.221.
  • Kong L, Berg FJ. 2018. Identification of cholecystokinin tetrapeptide amide metabolites in liver microsomes of human, Rhesus Monkey, Sprague-Dawley rat and CD1 mouse using ultra-high performance liquid chromatography coupled to high resolution mass spectrometer. J Chromatogr B Analyt Technol Biomed Life Sci. 1096:80–87. doi: 10.1016/j.jchromb.2018.08.012.
  • Remesic M, Hruby VJ, Porreca F, Lee YS. 2017. Recent advances in the realm of allosteric modulators for opioid receptors for future therapeutics. ACS Chem Neurosci. 8(6):1147–1158. doi: 10.1021/acschemneuro.7b00090.
  • Strain EC, Preston KL, Liebson IA, Bigelow GE. 1996. Opioid antagonist effects of dezocine in opioid-dependent humans. Clin Pharmacol Ther. 60(2):206–217. doi: 10.1016/S0009-9236(96)90137-X.
  • Volkow ND, McLellan AT. 2016. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med. 374(13):1253–1263. doi: 10.1056/NEJMra1507771.
  • Wang K, Chai L, Feng X, Liu Z, Liu H, Ding L, Qiu F. 2017. Metabolites identification of berberine in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal. 139:73–86. doi: 10.1016/j.jpba.2017.02.038.
  • Wang L, Liu X, Wang J, Sun Y, Zhang G, Liang L. 2017. Comparison of the efficacy and safety between dezocine injection and morphine injection for persistence of pain in Chinese cancer patients: a meta-analysis. Biosci Rep. 37(3):BSR20170243. doi: 10.1042/BSR20170243.
  • Wang Y-H, Chai J-R, Xu X-J, Ye R-F, Zan G-Y, Liu GY-K, Long J-D, Ma Y, Huang X, Xiao Z-C, et al. 2018. Pharmacological characterization of dezocine, a potent analgesic acting as a κ partial agonist and μ partial agonist. Sci Rep. 8(1):14087. doi: 10.1038/s41598-018-32568-y.
  • Yin J, Zhang X, Zhang Y, Ma Y, Li L, Li D, Zhang L, Zhang Z. 2019. Comprehensive study of the in vivo and in vitro metabolism of dietary isoflavone biochanin A based on UHPLC-Q-TOF-MS/MS. J Agric Food Chem. 67(45):12481–12495. doi: 10.1021/acs.jafc.9b05776.
  • Yuan S, Gao P, Shi Y, Tu P, Jiang Y. 2022. Rapid screening and identification of metabolites of murpanicin in rats by UHPLC/Q-TOF-MS/MS combined with diagnostic fragment ions (DFIs) and multiple mass defect filter. J Pharm Biomed Anal. 213:114679. doi: 10.1016/j.jpba.2022.114679.
  • Zhu Z-J, Schultz AW, Wang J, Johnson CH, Yannone SM, Patti GJ, Siuzdak G. 2013. Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database. Nat Protoc. 8(3):451–460. doi: 10.1038/nprot.2013.004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.